Imunon, Inc.
IMNN
$6.24
-$0.11-1.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -2.72M | -1.13M | 0.00 | 1.67M | 359.30K |
| Gross Profit | 2.72M | 1.13M | 0.00 | -1.67M | -359.30K |
| SG&A Expenses | 7.10M | 7.76M | 7.49M | 7.99M | 8.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.02M | 18.27M | 19.13M | 20.95M | 19.90M |
| Operating Income | -16.02M | -18.27M | -19.13M | -20.95M | -19.90M |
| Income Before Tax | -15.75M | -17.79M | -18.62M | -20.73M | -19.36M |
| Income Tax Expenses | -- | -- | -- | -1.28M | -1.28M |
| Earnings from Continuing Operations | -15.75 | -17.79 | -18.62 | -19.45 | -18.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.75M | -17.79M | -18.62M | -19.45M | -18.08M |
| EBIT | -16.02M | -18.27M | -19.13M | -20.95M | -19.90M |
| EBITDA | -15.78M | -18.03M | -18.89M | -20.68M | -19.62M |
| EPS Basic | -13.56 | -18.34 | -21.50 | -24.64 | -25.10 |
| Normalized Basic EPS | -8.48 | -11.46 | -13.44 | -16.51 | -16.80 |
| EPS Diluted | -13.56 | -18.34 | -21.50 | -24.64 | -25.10 |
| Normalized Diluted EPS | -8.48 | -11.46 | -13.44 | -16.51 | -16.80 |
| Average Basic Shares Outstanding | 4.81M | 4.06M | 3.66M | 3.27M | 2.88M |
| Average Diluted Shares Outstanding | 4.81M | 4.06M | 3.66M | 3.27M | 2.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |